| BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ a Karla PLEVOVÁ. Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method. Patent. Číslo: US 9,057,106. Vydavatel: United States Patents and Trademark. Místo vydání: USA. Název vlastníka: Masarykova univerzita. Datum registrace: 3. 8. 2010. Datum přijetí: 16. 6. 2015. 2015. |
Další formáty:
BibTeX
LaTeX
RIS
@misc{1341556,
author = {Bryja, Vítězslav and Krejčí, Pavel and Kaucká, Markéta and Pospíšilová, Šárka and Mayer, Jiří and Kozubík, Alois and Kotašková, Jana and Plevová, Karla},
keywords = {B Cell; Chronic Lymphotetic Leukemia; WNT/PCP Signaling Pathway},
language = {eng},
title = {Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method},
year = {2015}
}
TY - PAT
ID - 1341556
AU - Bryja, Vítězslav - Krejčí, Pavel - Kaucká, Markéta - Pospíšilová, Šárka - Mayer, Jiří - Kozubík, Alois - Kotašková, Jana - Plevová, Karla
PY - 2015
TI - Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method
KW - B Cell
KW - Chronic Lymphotetic Leukemia
KW - WNT/PCP Signaling Pathway
N2 - The invention provides a method of determination of diagnosis and prognosis of B-cell chronic lymphocytic leukemia from a biological sample collected from the body of a patient, wherein the status of Wnt/PCP signaling pathway is determined. Within the framework of the present invention the relation of CLL and molecular signaling pathway Wnt/PCP the components of which are markedly up-regulated in B-lymphocytes of the patients suffering from CLL was identified. The status of the Wnt/PCP signaling pathway can be determined, e.g., by the determination of the expression of components of said signaling pathway or by the determination of migration of CLL cells in the gradient of a chemokine in the presence of the ligand of said signaling pathway. The invention also relates to suitable oligonucleotides for use in the method of determination of expression of the signaling pathway components.
ER -
BRYJA, Vítězslav, Pavel KREJČÍ, Markéta KAUCKÁ, Šárka POSPÍŠILOVÁ, Jiří MAYER, Alois KOZUBÍK, Jana KOTAŠKOVÁ a Karla PLEVOVÁ. \textit{Method of Determination of Diagnosis and Prognosis in Patients with B-cell Chronic Lymphocytic leukemia and oligonucleotides for use in this method}. Patent. Číslo: US 9,057,106. Vydavatel: United States Patents and Trademark. Místo vydání: USA. Název vlastníka: Masarykova univerzita. Datum registrace: 3. 8. 2010. Datum přijetí: 16. 6. 2015. 2015.
|
